SCHEMBL6204464

SCHEMBL6204464

O=CNc1ccc2c(c1)COCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.38
RAB9A P51151 9/20 0.38
SMN1; SMN2 Q16637 9/20 0.38
NPC1 O15118 8/20 0.38
MEN1 O00255 7/20 0.38
KMT2A Q03164 7/20 0.38
ALDH1A1 P00352 6/20 0.38
GAA P10253 5/20 0.38
HSD17B10 Q99714 4/20 0.38
KDM4E B2RXH2 4/20 0.38
NFKB1 P19838 3/20 0.38
NFKB2 Q00653 3/20 0.38
RELA Q04206 3/20 0.38
ALOX12 P18054 3/20 0.38
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KIF11 P52732 1/20 0.37
HPGD P15428 4/20 0.36
PKM P14618 3/20 0.36
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16211043 0.78 KIF11 (0.40) MAPTRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL17361823 0.78 ALDH1A1 (0.39) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL182882 0.78 SMN1; SMN2 (0.58) MAPTRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL10843775 0.75 CYP1A2 (0.56) MAPTRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL10843574 0.75 ALDH1A1 (0.59) MAPTRAB9ANPC1MEN1KMT2A
SCHEMBL31024004 0.75 ALDH1A1 (0.59) MAPTRAB9ANPC1MEN1KMT2A
SCHEMBL20939584 0.74 DYRK1A (0.47) MAPTRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL28939591 0.72 ALDH1A1 (0.34) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL7007389 0.72 ALOX5 (0.33) MAPT
SCHEMBL5528669 0.72 RAB9A (0.55) MAPTRAB9ASMN1; SMN2NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534681-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-06-01 EP disclosed
WO-2004002960-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-01-08 WO disclosed